KEDW (Epigenetic Bioregulator)
KEDW (Lys-Glu-Asp-Trp) is a synthetic tetrapeptide bioregulator investigated for its broad epigenetic effects across multiple tissues, including chromatin remodeling, multi-organ gene expression modulation, and epigenetic aging reversal.
KEDW (Lys-Glu-Asp-Trp) is a synthetic tetrapeptide from the Khavinson bioregulatory peptide series, distinguished by its broad multi-tissue epigenetic activity. While most Khavinson tetrapeptides exhibit tissue-preferential effects, KEDW has been investigated for its capacity to modulate chromatin structure and gene expression across multiple organ systems simultaneously.
Overview
Epigenetic aging is characterized by progressive changes in DNA methylation, histone modification, and chromatin architecture that accumulate across all tissues with age. These changes lead to silencing of genes required for tissue maintenance and inappropriate activation of inflammatory and senescence-associated genes. The epigenetic clock concept, established by Horvath (2013), demonstrated that DNA methylation patterns track biological age across multiple tissues with remarkable consistency.
KEDW's multi-tissue epigenetic activity positions it within this framework as a potential modulator of systemic epigenetic drift. Unlike tissue-specific bioregulators such as Cardiogen (heart), Bronchogen (lung), or Pinealon (brain), KEDW has been studied for effects across multiple tissue types, suggesting it may interact with chromatin regions that are commonly accessible across diverse cell types.
Mechanism of Action
KEDW's mechanism operates within the bioregulatory peptide framework described by Khavinson (2002), with particular emphasis on chromatin-level effects.
Chromatin Remodeling: Khavinson et al. (2004) demonstrated that short peptides including those with similar structural properties to KEDW can induce decondensation of heterochromatin in lymphocytes from elderly subjects. The tryptophan residue in KEDW's sequence is notable, as tryptophan's indole ring system is known to intercalate with DNA structures, potentially enhancing chromatin-remodeling capacity. Lezhava et al. (2006) extended these findings to show reactivation of silenced chromatin regions in aging cells treated with bioregulatory peptides.
Multi-Gene Expression Modulation: The charged amino acid composition of KEDW (two acidic residues: Glu, Asp; one basic: Lys; plus aromatic Trp) provides a physicochemical profile suited for interaction with DNA minor groove regions across multiple gene promoters. Khavinson et al. (2009) characterized how short peptide sequences interact with DNA in a sequence-specific manner, with binding affinity determined by the peptide's charge distribution and aromatic character.
Epigenetic Reprogramming: KEDW's broad-spectrum activity suggests it may target chromatin modifications common to aging across tissues — such as age-related increases in heterochromatin at previously active gene loci, or dysregulation of histone acetylation patterns. This positions KEDW as a potential epigenetic reprogramming agent operating at the chromatin accessibility level.
Reconstitution Calculator
Reconstitution Calculator
Calculate your peptide dosing
Set up a clean workspace with all supplies ready.
7x / week for weeks
Research
Peptide Bioregulation and Lifespan
Khavinson and Anisimov (2003) reviewed evidence that bioregulatory peptides can extend lifespan in experimental models, an effect attributed to normalization of gene expression across multiple aging organ systems. This systemic anti-aging effect is most consistent with peptides that have multi-tissue activity, positioning KEDW within the class of broadly acting epigenetic bioregulators.
Chromatin Structure in Aging
Khavinson et al. (2004) established that bioregulatory peptides can reverse age-related chromatin condensation in human lymphocytes. Elderly subjects showed significantly increased heterochromatin, and peptide treatment restored chromatin accessibility toward patterns observed in younger individuals. This foundational work demonstrates the principle that short peptides can modulate the epigenetic state of aging cells, the core mechanism proposed for KEDW's multi-tissue activity.
Gene Expression Across Tissues
Anisimov et al. (2004) used microarray analysis to characterize how short peptides alter gene expression across functionally diverse gene families including apoptosis regulation, stress response, signal transduction, and matrix maintenance. The breadth of gene expression changes observed supports the concept of chromatin-level modulation affecting multiple downstream pathways simultaneously — the proposed mode of action for a multi-tissue epigenetic bioregulator like KEDW.
Short Peptide-DNA Binding Specificity
Khavinson et al. (2009) provided molecular-level evidence for sequence-specific binding of short peptides to double-stranded DNA. The study demonstrated that peptides interact with the DNA minor groove, with binding characteristics determined by the peptide's amino acid composition. KEDW's combination of charged and aromatic residues gives it a distinct DNA-binding profile that may account for its broader tissue activity compared to peptides with more restricted binding preferences.
Safety Profile
KEDW has been investigated in preclinical models within the Khavinson bioregulatory peptide research program with no significant adverse effects reported. As a short tetrapeptide composed of natural amino acids (Lys, Glu, Asp, Trp), it is expected to undergo rapid enzymatic degradation to constituent amino acids. The multi-tissue nature of KEDW's activity raises theoretical questions about off-target gene expression effects, though no adverse consequences have been reported in available literature. Formal toxicology studies meeting international regulatory standards have not been published. The natural amino acid composition and low molecular weight suggest minimal immunogenicity risk.
Pharmacokinetic Profile
- Half-life
- Not established
Quick Start
- Route
- Subcutaneous injection
Molecular Structure
- Formula
- C₂₃H₃₁N₅O₈
- CAS
- Not established
Research Protocols
subcutaneous Injection
Administered via subcutaneous injection.
Quality Indicators
What to look for
- Multiple peer-reviewed studies available
Frequently Asked Questions
References (9)
- [2]
- [7]
- [8]Khavinson VK et al Peptides and Aging Int J Mol Sci (2020)
- [6]
- [3]Khavinson VK, Lezhava TA, Malinin VV Effects of short peptides on lymphocyte chromatin in senile subjects Bull Exp Biol Med (2004)
- [1]Khavinson VK Peptides and Ageing Neuro Endocrinol Lett (2002)
- [4]Anisimov SV, Khavinson VK, Anisimov VN Elucidation of the effect of brain cortex tetrapeptide Cortagen on gene expression in mouse heart by microarray Neuro Endocrinol Lett (2004)
- [5]Lezhava T et al Anti-aging peptide bioregulators induce reactivation of chromatin Georgian Med News (2006)
- [9]Khavinson VK et al Peptide Regulation of Gene Expression and Protein Synthesis in Bronchial Epithelium Molecules (2021)
Ipamorelin
Ipamorelin is a highly selective growth hormone secretagogue pentapeptide that binds the ghrelin receptor without affecting ACTH, prolactin, or cortisol release. It is researched for applications in bone health, muscle preservation, diabetes, and gastrointestinal motility.
KGF (Keratinocyte Growth Factor)
KGF (FGF-7) is a 163-amino acid growth factor that specifically targets keratinocytes via the FGFR2-IIIb receptor, with clinical applications in mucositis treatment, wound healing, and hair follicle biology.